CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Zopiclone

佐匹克隆 杂质对照品Zopiclone Impurities

EP46 个杂质条目46 impurity entries

本页汇总 佐匹克隆 的 46 个杂质对照品条目,其中药典杂质标注了 EP/USP 编号。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 46 impurity reference standards of Zopiclone with EP/USP numbering where applicable. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 佐匹克隆(Zopiclone)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesSimultaneous determination of zopiclone and its degradation product and main impurity (2-amino-5-chloropyridine) by micellar liquid chromatography with time-programmed fluorescence detection: preliminary investigation for biological monitoring
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences · 2012 · El-Shaheny RN et al.  ·  PMID 22999478  ·  DOI
  2. 杂质研究Impurity studiesFirst derivative spectrofluorimetric determination of zopiclone and its degradation product, 2-amino-5-chloropyridine, in pharmaceutical formulations with preliminary tool in biological fluids for clinical evidence of zopiclone intake
    Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy · 2017 · Al-Attas AS et al.  ·  PMID 28359903  ·  DOI
  3. 杂质研究Impurity studiesQuantitative determination of zopiclone and its impurity by four different spectrophotometric methods
    Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy · 2015 · Abdelrahman MM et al.  ·  PMID 25244295  ·  DOI
  4. 分析方法Analytical MethodsEnantioselective separation of zopiclone on immobilized polysaccharide chiral stationary phase by HPLC: Method development and validation
    Journal of pharmaceutical and biomedical analysis · 2020 · Kozlov O et al.  ·  PMID 32846404  ·  DOI
  5. 分析方法Analytical MethodsEvaluation of the stability and cross-reactivity of zopiclone and eszopiclone using immunoassay kits
    The Journal of toxicological sciences · 2026 · Saito T et al.  ·  PMID 41765457  ·  DOI

佐匹克隆 —— 原料药与杂质对照品Zopiclone — drug substance & impurities

共 46 个条目(含原料药本体)46 items incl. the drug substance
Zopiclone Impurity 1 (Zopiclone EP Impurity A) structure
EPA
佐匹克隆杂质1(佐匹克隆EP杂质A)Zopiclone Impurity 1 (Zopiclone EP Impurity A)
Zopiclone Impurity 1 (Zopiclone EP Impurity A)
CAS No.43200-96-0
Chemical FormulaC17H17ClN6O4
Purity>95%询价On request
10mg25mg50mg100mg
Zopiclone Impurity 2 (Zopiclone EP Impurity B) structure
EPB
佐匹克隆杂质2(佐匹克隆EP杂质B)Zopiclone Impurity 2 (Zopiclone EP Impurity B)
Zopiclone Impurity 2 (Zopiclone EP Impurity B)
CAS No.43200-81-3
Chemical FormulaC11H7ClN4O2
Purity>95%询价On request
10mg25mg50mg100mg
Zopiclone Impurity 3 (Zopiclone EP Impurity C) structure
EPC
佐匹克隆杂质3(佐匹克隆EP杂质C)Zopiclone Impurity 3 (Zopiclone EP Impurity C)
Zopiclone Impurity 3 (Zopiclone EP Impurity C)
CAS No.148891-53-6
Chemical FormulaC11H7ClN4O
Purity>95%询价On request
10mg25mg50mg100mg
Zopiclone Impurity 1-d8 (Zopiclone EP Impurity A-d8) structure
EPA-D8
佐匹克隆杂质1-d8 (佐匹克隆EP杂质A-d8)Zopiclone Impurity 1-d8 (Zopiclone EP Impurity A-d8)
Zopiclone Impurity 1-d8 (Zopiclone EP Impurity A-d8)
CAS No.1215741-18-6
Chemical FormulaC17H9D8ClN6O4
Purity>95%询价On request
Zopiclone-d4A structure
—
佐匹克隆-d4AZopiclone-d4A
Zopiclone-d4A
CAS No.1435933-78-0
Chemical FormulaC17H13D4ClN6O3
Purity>95%询价On request
10mg25mg50mg100mg
Zopiclone Impurity 4 ((R)-Zopiclone) structure
4
佐匹克隆杂质4((R)-佐匹克隆)Zopiclone Impurity 4 ((R)-Zopiclone)
Zopiclone Impurity 4 ((R)-Zopiclone)
CAS No.138680-08-7
Chemical FormulaC17H17ClN6O3
Purity>95%询价On request
10mg25mg50mg100mg
Zopiclone Impurity 5 structure
5
佐匹克隆杂质5Zopiclone Impurity 5
Zopiclone Impurity 5
CAS No.1348046-61-6
Chemical FormulaC17H18N6O3
Purity>95%询价On request
10mg25mg50mg100mg
Zopiclone Impurity 6 Monomer structure
6
佐匹克隆杂质6 单体Zopiclone Impurity 6 Monomer
Zopiclone Impurity 6 Monomer
CAS No.151776-26-0
Chemical FormulaC16H15ClN6O3
Purity>95%询价On request
10mg25mg50mg100mg
Zopiclone Impurity 6 structure
6
佐匹克隆杂质6Zopiclone Impurity 6
Zopiclone Impurity 6
CAS No.300701-71-7
Chemical FormulaC16H15ClN6O3·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Zopiclone Impurity 7 structure
7
佐匹克隆杂质7Zopiclone Impurity 7
Zopiclone Impurity 7
CAS No.43200-82-4
Chemical FormulaC11H5ClN4O2
Purity>95%询价On request
10mg25mg50mg100mg
Zopiclone Impurity 8 structure
8
佐匹克隆杂质8Zopiclone Impurity 8
Zopiclone Impurity 8
CAS No.89-01-0
Chemical FormulaC6H4N2O4
Purity>95%询价On request
10mg25mg50mg100mg
Zopiclone Impurity 9 structure
9
佐匹克隆杂质9Zopiclone Impurity 9
Zopiclone Impurity 9
CAS No.4744-50-7
Chemical FormulaC6H2N2O3
Purity>95%询价On request
10mg25mg50mg100mg
Zopiclone Impurity 10 structure
10
佐匹克隆杂质10Zopiclone Impurity 10
Zopiclone Impurity 10
CAS No.43200-83-5
Chemical FormulaC11H7ClN4O3
Purity>95%询价On request
10mg25mg50mg100mg
Zopiclone Impurity 12 structure
12
佐匹克隆杂质12Zopiclone Impurity 12
Zopiclone Impurity 12
CAS No.39539-66-7
Chemical FormulaC6H11ClN2O
Purity>95%询价On request
10mg25mg50mg100mg
Zopiclone Impurity 12 Hydrochloride structure
12
佐匹克隆杂质12 盐酸盐Zopiclone Impurity 12 Hydrochloride
Zopiclone Impurity 12 Hydrochloride
CAS No.55112-42-0
Chemical FormulaC6H11ClN2O·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Zopiclone Impurity 18 structure
18
佐匹克隆杂质18Zopiclone Impurity 18
Zopiclone Impurity 18
CAS No.4180-30-7
Chemical FormulaC11H22N4O
Purity>95%询价On request
10mg25mg50mg100mg
Zopiclone Impurity 19 structure
19
佐匹克隆杂质19Zopiclone Impurity 19
Zopiclone Impurity 19
CAS No.59325-11-0
Chemical FormulaC8H16N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Zopiclone Impurity 20 Dihydrochloride structure
20
佐匹克隆杂质20 双盐酸盐Zopiclone Impurity 20 Dihydrochloride
Zopiclone Impurity 20 Dihydrochloride
CAS No.53788-47-9
Chemical FormulaC5H12N2O·2HCl
Purity>95%询价On request
10mg25mg50mg100mg
Zopiclone Impurity 20 structure
20
佐匹克隆杂质20Zopiclone Impurity 20
Zopiclone Impurity 20
CAS No.75020-12-1
Chemical FormulaC5H12N2O
Purity>95%询价On request
10mg25mg50mg100mg
Zopiclone Impurity 22 structure
22
佐匹克隆杂质22Zopiclone Impurity 22
Zopiclone Impurity 22
CAS No.45965-30-8
Chemical FormulaC7H7ClN2O
Purity>95%询价On request
10mg25mg50mg100mg
Zopiclone Impurity 23 structure
23
佐匹克隆杂质23Zopiclone Impurity 23
Zopiclone Impurity 23
CAS No.1122549-43-2
Chemical FormulaC11H9ClN4O2
Purity>95%询价On request
10mg25mg50mg100mg
Zopiclone Impurity 25 structure
25
佐匹克隆杂质25Zopiclone Impurity 25
Zopiclone Impurity 25
CAS No.1369509-04-5
Chemical FormulaC17H17BrN6O3
Purity>95%询价On request
10mg25mg50mg100mg
Zopiclone Impurity 27 structure
27
佐匹克隆杂质27Zopiclone Impurity 27
Zopiclone Impurity 27
CAS No.43200-88-0
Chemical FormulaC18H11ClN4O4
Purity>95%询价On request
10mg25mg50mg100mg
Zopiclone Impurity 28 structure
28
佐匹克隆杂质28Zopiclone Impurity 28
Zopiclone Impurity 28
CAS No.349125-10-6
Chemical FormulaC10H7ClN4O
Purity>95%询价On request
10mg25mg50mg100mg
Zopiclone Impurity 31 structure
31
佐匹克隆杂质31Zopiclone Impurity 31
Zopiclone Impurity 31
CAS No.69433-07-4
Chemical FormulaC5H9ClN2O
Purity>95%询价On request
10mg25mg50mg100mg
Zopiclone Impurity 32 structure
32
佐匹克隆杂质32Zopiclone Impurity 32
Zopiclone Impurity 32
CAS No.7560-85-2
Chemical FormulaC7H14N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Zopiclone Impurity 33 structure
33
佐匹克隆杂质33Zopiclone Impurity 33
Zopiclone Impurity 33
CAS No.1566873-38-8
Chemical FormulaC9H18N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Zopiclone Impurity 34 structure
34
佐匹克隆杂质34Zopiclone Impurity 34
Zopiclone Impurity 34
CAS No.39546-32-2
Chemical FormulaC6H12N2O
Purity>95%询价On request
10mg25mg50mg100mg
Zopiclone Impurity 35 Monomer-d8 structure
35
佐匹克隆杂质35 单体-d8Zopiclone Impurity 35 Monomer-d8
Zopiclone Impurity 35 Monomer-d8
CAS No.1189805-43-3
Chemical FormulaC16H7D8ClN6O3
Purity>95%询价On request
Zopiclone Impurity 35 structure
35
佐匹克隆杂质35Zopiclone Impurity 35
Zopiclone Impurity 35
CAS No.1216659-29-8
Chemical FormulaC16H15ClN6O3·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Zopiclone Impurity 35 Monomer structure
35
佐匹克隆杂质35 单体Zopiclone Impurity 35 Monomer
Zopiclone Impurity 35 Monomer
CAS No.59878-63-6
Chemical FormulaC16H15ClN6O3
Purity>95%询价On request
10mg25mg50mg100mg
Zopiclone Impurity 36 structure
36
佐匹克隆杂质36Zopiclone Impurity 36
Zopiclone Impurity 36
CAS No.1076199-62-6
Chemical FormulaC21H23ClN6O5
Purity>95%询价On request
10mg25mg50mg100mg
Zopiclone Impurity 37 Sodium Salt structure
37
佐匹克隆杂质37 钠盐Zopiclone Impurity 37 Sodium Salt
Zopiclone Impurity 37 Sodium Salt
CAS No.864920-32-1
Chemical FormulaC6H3N2O3-·Na+
Purity>95%询价On request
10mg25mg50mg100mg
Zopiclone Impurity 37 structure
37
佐匹克隆杂质37Zopiclone Impurity 37
Zopiclone Impurity 37
CAS No.865061-50-3
Chemical FormulaC6H4N2O3
Purity>95%询价On request
10mg25mg50mg100mg
Zopiclone Impurity 38 structure
38
佐匹克隆杂质38Zopiclone Impurity 38
Zopiclone Impurity 38
CAS No.151851-70-6
Chemical FormulaC17H17ClN6O4
Purity>95%询价On request
10mg25mg50mg100mg
Zopiclone Impurity 39 structure
39
佐匹克隆杂质39Zopiclone Impurity 39
Zopiclone Impurity 39
CAS No.1177312-44-5
Chemical FormulaC9H18N2·C2H2O4
Purity>95%询价On request
10mg25mg50mg100mg
Zopiclone Impurity 40 structure
40
佐匹克隆杂质40Zopiclone Impurity 40
Zopiclone Impurity 40
CAS No.100158-79-0
Chemical FormulaC12H24N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Zopiclone Impurity 41 structure
41
佐匹克隆杂质41Zopiclone Impurity 41
Zopiclone Impurity 41
CAS No.2829521-02-8
Chemical FormulaC17H19ClN6O3
Purity>95%询价On request
10mg25mg50mg100mg
Zopiclone Impurity 42 structure
42
佐匹克隆杂质42Zopiclone Impurity 42
Zopiclone Impurity 42
CAS No.1789305-52-7
Chemical FormulaC12H17N3O
Purity>95%询价On request
10mg25mg50mg100mg
Zopiclone Impurity 43 structure
43
佐匹克隆杂质43Zopiclone Impurity 43
Zopiclone Impurity 43
CAS No.1582535-63-4
Chemical FormulaC18H24N4O
Purity>95%询价On request
10mg25mg50mg100mg
Zopiclone Impurity 44 structure
44
佐匹克隆杂质44Zopiclone Impurity 44
Zopiclone Impurity 44
CAS No.17696-90-1
Chemical FormulaC12H22N4O2
Purity>95%询价On request
10mg25mg50mg100mg
Zopiclone Impurity 45 (N-Nitroso Zopiclone Impurity 34) structure
45
佐匹克隆杂质45 (N-亚硝基佐匹克隆杂质34)Zopiclone Impurity 45 (N-Nitroso Zopiclone Impurity 34)
Zopiclone Impurity 45 (N-Nitroso Zopiclone Impurity 34)
CAS No.1254360-38-7
Chemical FormulaC6H11N3O2
Purity>95%询价On request
10mg25mg50mg100mg
Zopiclone Impurity 48 structure
48
佐匹克隆杂质48Zopiclone Impurity 48
Zopiclone Impurity 48
CAS No.1400787-78-1
Chemical FormulaC11H7ClN4O2
Purity>95%询价On request
10mg25mg50mg100mg
Zopiclone Impurity 29-d8 (Eszopiclone-d8) structure
29-D8
佐匹克隆杂质29-d8 (右旋佐匹克隆-d8)Zopiclone Impurity 29-d8 (Eszopiclone-d8)
Zopiclone Impurity 29-d8 (Eszopiclone-d8)
CAS No.1093385-24-0
Chemical FormulaC17H9D8ClN6O3
Purity>95%询价On request
Zopiclone Impurity 35-d8 structure
35-D8
佐匹克隆杂质35-d8Zopiclone Impurity 35-d8
Zopiclone Impurity 35-d8
CAS No.1189719-74-1
Chemical FormulaC16H7D8ClN6O3·HCl
Purity>95%询价On request
Zopiclone Impurity 36-d8 structure
36-D8
佐匹克隆杂质36-d8Zopiclone Impurity 36-d8
Zopiclone Impurity 36-d8
CAS No.1246820-47-2
Chemical FormulaC21H15D8ClN6O5
Purity>95%询价On request
本品种含亚硝胺类杂质条目。亚硝胺杂质属于 ICH M7 关注的潜在致突变杂质,建议在方法开发中纳入专属性考察。This list includes nitrosamine entries. Nitrosamines are potential mutagenic impurities under ICH M7 and should be covered by a specific method.

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

佐匹克隆 —— 研究文献与合成路线Zopiclone — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 佐匹克隆 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Zopiclone. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Capillary electrophoretic enantioselective determination of zopiclone and its impurities
    Tonon MA, Bonato PS · Electrophoresis · 2012 · 被引 13cited 13
  2. Identification and characterization of new impurities in zopiclone tablets by LC-QTOF-MS
    Han X, Cheng FJ, Di B, et al. · Journal of pharmaceutical and biomedical analysis · 2021 · 被引 5cited 5
  3. Quantitative determination of zopiclone and its impurity by four different spectrophotometric methods
    Abdelrahman MM, Naguib IA, El Ghobashy MR, et al. · Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy · 2015 · 被引 6cited 6
  4. A method for the rapid detection of the zopiclone degradation product 2-amino-5-chloropyridine
    Galloway JH, Marsh ID, Newton CM, et al. · Science & justice : journal of the Forensic Science Society · 1999 · 被引 6cited 6
  5. HPTLC Method for Quantitative Determination of Zopiclone and Its Impurity
    Naguib IA, Abdelrahman MM, El Ghobashy MR, et al. · Journal of chromatographic science · 2015 · 被引 2cited 2

合成与制备工艺专利Synthesis & process patents

  1. PROCESS FOR THE RESOLUTION OF ZOPICLONE AND INTERMEDIATE COMPOUNDS
    BLEDA DAVID FERNANDEZ, TOUS JORDI LLUYS · 公开号 HRP20120306THRP20120306T · 2012
  2. PROCESS FOR RESOLVING ZOPICLONE
    RAO DHARMARAJ RAMCHANDRA, KANKAN RAJENDRA NARAYANRAO, GHAGARE MARUTI GANPATI, SAROJ SUNILKUMAR PARASNATH · 公开号 EP2356121EP2356121 · 2011
  3. PROCESS FOR RESOLVING ZOPICLONE
    RAO DHARAMARAJ RAMCHANDRA, KANKAN RAJENDRA NARAYANRAO, GHAGARE MARUTI GANPATI, SAROJ SUNILKUMAR PARASNATH · 公开号 WO2010052475WO2010052475 · 2010
  4. PROCESS FOR RESOLVING ZOPICLONE
    RAO DHARMARAJ RAMACHANDRA, KANKAN RAJENDRA NARAYANRAO, GHAGARE MARUTI GANPATI, SAROJ SUNILKUMAR PARASNATH · 公开号 NZ592976NZ592976 · 2012
  5. Process for Resolving Zopiclone
    RAO DHARMARAJ RAMACHANDRA, KANKAN RAJENDRA NARAYANRAO, GHAGARE MARUTI GANPATI, SAROJ SUNILKUMAR PARASNATH · 公开号 US2011245499US2011245499 · 2011

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

佐匹克隆 杂质谱研究要点Zopiclone — impurity profiling notes

下面这些是拿到 佐匹克隆 的 46 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 46 impurity entries for Zopiclone, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

本品种含药典编号杂质(EP/USP)。申报时药典已收载的杂质通常需要逐项对照,建议优先备齐药典编号对照品,再补充工艺与降解杂质。This drug substance includes pharmacopoeially designated impurities (EP/USP). Monographed impurities normally need item-by-item comparison during filing, so secure the pharmacopoeial standards first, then fill in process and degradation impurities.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances